(177)Lu-DOTATATE therapy in metastatic/inoperable pheochromocytoma-paraganglioma

INTRODUCTION: (177)Lu-DOTATATE-based peptide receptor radionuclide therapy (PRRT) is a promising therapy for metastatic and/or inoperable pheochromocytoma and paraganglioma (PPGL). We aim to evaluate the efficacy and safety of and identify predictors of response to (177)Lu-DOTATATE therapy in metast...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Endocr Connect
Main Authors: Kumar Jaiswal, Sanjeet, Sarathi, Vijaya, Samad Memon, Saba, Garg, Robin, Malhotra, Gaurav, Verma, Priyanka, Shah, Ravikumar, Kaur Sehemby, Manjeet, A Patil, Virendra, Jadhav, Swati, Ranjan Lila, Anurag, S Shah, Nalini, R Bandgar, Tushar
Formato: Artigo
Idioma:Inglês
Publicado em: Bioscientifica Ltd 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7487189/
https://ncbi.nlm.nih.gov/pubmed/32784267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-20-0292
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados